Loeb Seeks Head Of Pharmaceutical CEO

Jul 17 2007 | 2:05pm ET

Patience is not one of Daniel Loeb’s more prominent virtues: Just a month after meeting with independent directors of PDL BioPharma, Loeb fired off a letter to them complaining of their inaction and demanding—what else?—a firing.

Loeb, founder of the activist New York hedge fund Third Point, wrote, in a letter dated yesterday, “Although we understand that you recently directed your financial and business advisors to explore all options to increase shareholder value, we believe that directive will prove futile so long as Mr. [Mark] McDade remains CEO.” Loeb goes on to demand three seats on the board of the Fremont, Calif.-based pharmaceutical company in addition to McDade’s immediate dismissal.

After a legal—some might say patronizing—discussion of the fiduciary responsibilities of independent directors, to wit, “terminate Mr. McDade before he is allowed to destroy shareholder value at our company for even one more day,” Loeb details six examples of McDade’s alleged “record of incompetence, egregiously bad business judgment and serious ethical lapses.”

Third point controls roughly 9.8% of PDL’s outstanding shares.

In addition to McDade’s head and a trio of board seats, Loeb also calls on the board to “slow the progression of the Ularitide & Nuvion Partnerships until all alternatives are considered.”

Meanwhile, another company target by Third Point is out one long-time executive.

Richmond, Va.-based Massey Energy Co. said today that H. Drexel Short, senior vice president of group operations, had left the firm after more than 25 years. The coal mining company, which faces a slew of legal troubles in addition to Loeb’s wrath, offered no explanation for Short’s resignation.

Last month, Loeb and Third Point analyst Todd Swanson quit the Massey board over—you guessed it—the board’s refusal to fire Massey CEO Don Blankenship.


In Depth

Kettera Q&A: The Advantages of Alternative Investment Platforms

Oct 28 2016 | 5:52pm ET

The past several years have seen a distinct push towards easier and cheaper access...

Lifestyle

Midtown's Plaza District Fades As Manhattan Office Landscape Shifts

Nov 22 2016 | 6:32pm ET

Lower leasing costs, more efficient office space and the hope of projecting an image...

Guest Contributor

Nowhere to Hide: Why the Future of Asset Management Depends on Innovation

Nov 15 2016 | 6:55pm ET

Information technology has reshaped the asset management industry’s periphery,...

 

From the current issue of

Chicago-based independent futures brokerage and clearing firm R.J. O’Brien & Associates (RJO) has hired industry veteran Daniel Staniford as Executive Director, responsible for the firm’s institutional business development in New York and London.

AVAILABLE NOW at BARNES & NOBLE

NEWSTAND LOCATOR